422 KZR-540 is a novel oral small molecule inhibitor of Sec61 cotranslational translocation that potently and selectively blocks PD-1 expression

Abstract

BackgroundBlocking the PD-1/PD-L1 pathway with antibodies has been effective in treating multiple types of cancers. However, orally administered small molecules can allow for better tumor penetrance and more convenient dosing...